Immunotherapy is redefining how doctors treat women diagnosed with stage 4 cervical cancer – offering hope where traditional treatments often fall short. According to global cancer statistics provided ...

Mabwell (688062.SH), an innovation-driven biopharmaceutical company with a fully integrated industrial chain, announced that a recent clinical case report on its self-developed novel Nectin-4 ...

Safety featured universal TEAEs and 92% grade ≥3 events; anemia (39.5%) predominated, discontinuations were frequent, and ...

Combination with investigational antibody-drug conjugate showed encouraging antitumor acti ...

Keytruda's first approval by US FDA came in the year 2014 for advanced skin cancer. Now, the immunotherapy drug is being used ...

Researchers found that 51% of cervical cancer clinical trials excluded all individuals living with HIV. Individuals living ...

With an estimated 12,000 new cervical cancer cases and over 8,000 deaths annually, Nigeria bears the highest burden of cervical cancer in Africa—and ranks seventh globally. It’s a devastating but ...